Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

The Bank of Japan likely won’t change policy abruptly enough to derail budget discussions, according to a senior member of an opposition party whose support is needed by Prime Minister Shigeru ...

The Bank of Japan likely won’t change policy abruptly enough to derail budget discussions, according to a senior member of an ...

Minister for Education, Aseri Radrodro confirms they will need to initiate an urgent investigation that will need to involve ...

THE High Court has issued orders mandating that seven police officers who were discharged last week Monday on charges of ...

In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) ...

A recent groundbreaking study found that Glucagon-like peptide 1 receptor agonists (GLP1-RA) are effective in reducing venous ...

Democratic Progressive Party (DPP) Legislator-at-large Hung Sun-han (洪申翰) has been chosen to succeed Ho Pei-shan (何佩珊) as ...

President William Ruto on Thursday fired a warning to investigative agencies including the Director of Public Prosecutions ...

More than $481 million was channelled to the businessman’s personal bank accounts, said the prosecutor. Read more at ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE).

Jamal Mirdad Khairrudin, 41 (in green T-shirt) was charged in having possession of ketum in Ipoh magistrate court. IPOH: A 41 ...